News Detail
Washington, 19 Oct 2023: Dabur India said on Wednesday its subsidiaries were among companies sued in the U.S. and Canada by customers alleging that the use of hair relaxer products had caused ovarian cancer, uterine cancer and other health issues.
“Unsubstantia......
View Details
“Unsubstantia......
View Details
Source : Reuters
dabur india
dabur international
hair relaxer
ovarian cancer
uterine cancer
Related News
- 1900 packings of fake Fair and Glow, Ponds Cream recovered (08-12-2023)
- India plans a digital Drug Regulatory System (08-12-2023)
- First Acute Kidney Injury Diagnostic Test Wins FDA Clearance (08-12-2023)
- Indian pharma companies recorded 9 percent 5-year CAGR (08-12-2023)
- Two crore alcoholic herbal syrup bottles sold across Saurashtra since 2023 (08-12-2023)
- Telangana DCA tightens noose against spurious drug manufacturers following seizure of spurious cancer drugs (08-12-2023)
- US FDA India & DIA India to host series of workshops on generic drug life-cycle management (08-12-2023)
- Gujarat: 8 arrested for manufacture, sale of beer in guise of Ayurvedic syrup (08-12-2023)
- WHO: More contaminated medicinal syrups found in new regions, including Southeast Asia (08-12-2023)
- IPC issues alert for painkiller mefenamic acid (08-12-2023)